Opus Genetics, Stock Alpha and Beta Analysis
| IRD Stock | 1.95 0.04 2.01% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Opus Genetics,. It also helps investors analyze the systematic and unsystematic risks associated with investing in Opus Genetics, over a specified time horizon. Remember, high Opus Genetics,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Opus Genetics,'s market risk premium analysis include:
Beta 1.25 | Alpha 0.21 | Risk 4.23 | Sharpe Ratio 0.0505 | Expected Return 0.21 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Opus Genetics, Backtesting, Opus Genetics, Valuation, Opus Genetics, Correlation, Opus Genetics, Hype Analysis, Opus Genetics, Volatility, Opus Genetics, History and analyze Opus Genetics, Performance. Opus Genetics, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Opus Genetics, market risk premium is the additional return an investor will receive from holding Opus Genetics, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Opus Genetics,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Opus Genetics,'s performance over market.| α | 0.21 | β | 1.25 |
Opus Genetics, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Opus Genetics,'s Buy-and-hold return. Our buy-and-hold chart shows how Opus Genetics, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Opus Genetics, Market Price Analysis
Market price analysis indicators help investors to evaluate how Opus Genetics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Opus Genetics, shares will generate the highest return on investment. By understating and applying Opus Genetics, stock market price indicators, traders can identify Opus Genetics, position entry and exit signals to maximize returns.
Opus Genetics, Return and Market Media
The median price of Opus Genetics, for the period between Wed, Oct 1, 2025 and Tue, Dec 30, 2025 is 2.0 with a coefficient of variation of 8.05. The daily time series for the period is distributed with a sample standard deviation of 0.16, arithmetic mean of 2.01, and mean deviation of 0.11. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | What MACD trends signal for Opus Genetics Inc. stock - Earnings Growth Summary AI Driven Stock Movement Reports - newser.com | 10/21/2025 |
2 | Opus Genetics Announces 23 Million Registered Direct Offering | 11/06/2025 |
3 | FY2025 Earnings Estimate for Opus Genetics Issued By Wedbush | 11/19/2025 |
4 | Opus Genetics Inc R3X1 Stock Analysis and Forecast - Currency Fluctuation Impact Consistent High Yield Stocks - earlytimes.in | 11/24/2025 |
5 | Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635 | 12/02/2025 |
6 | Why Opus Genetics Inc. stock gets analyst attention - Options Play High Accuracy Trade Signal Alerts - Newser | 12/04/2025 |
7 | Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 12 Trial in Best Disease | 12/09/2025 |
8 | Subdued Growth No Barrier To Opus Genetics, Inc. With Shares Advancing 27 | 12/11/2025 |
About Opus Genetics, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Opus or other stocks. Alpha measures the amount that position in Opus Genetics, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 4.52E-4 | 0.0615 | 0.71 | 0.61 | Revenue Per Share | 2.0 | 0.88 | 0.41 | 0.39 |
Opus Genetics, Investors Sentiment
The influence of Opus Genetics,'s investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Opus. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Opus Genetics,'s public news can be used to forecast risks associated with an investment in Opus. The trend in average sentiment can be used to explain how an investor holding Opus can time the market purely based on public headlines and social activities around Opus Genetics,. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Opus Genetics,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Opus Genetics,'s and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Opus Genetics,'s news discussions. The higher the estimated score, the more favorable is the investor's outlook on Opus Genetics,.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Opus Genetics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Opus Genetics,'s short interest history, or implied volatility extrapolated from Opus Genetics, options trading.
Build Portfolio with Opus Genetics,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Opus Genetics, Backtesting, Opus Genetics, Valuation, Opus Genetics, Correlation, Opus Genetics, Hype Analysis, Opus Genetics, Volatility, Opus Genetics, History and analyze Opus Genetics, Performance. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Opus Genetics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.